Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Hidden Causes of Obesity: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)

Obesity-drug makers Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)VIVUS Inc. (NASDAQ:VVUS), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) are three of the mostly hotly debated stocks in the biotech space. The fact that obesity afflicts more than 35% of American adults today defines the massive market opportunity these three companies have, but investors may not completely understand the nuances of this complex disease. For instance, how do clinicians approach the treatment of obesity? Are medications an integral part of treatment, or are lifestyle changes more important? Can obesity be cured?

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

To shed light on these topics, Motley Fool health-care analyst Max Macaluso spoke with Dr. Domenica Rubino, a weight-management expert and representative of The Obesity Society. In the following video segment from their discussion, Dr. Rubino discusses what can cause obesity in addition to a poor diet. A transcript follows the video.

Who will win the obesity drug market?
Can VIVUS Inc. (NASDAQ:VVUS) pick up its lagging sales and fend off the competition, or will Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reign supreme in the obesity space? If you’re in the dark, grab copies of The Motley Fool’s premium research reports on VIVUS and Arena Pharmaceuticals to stay up to date. Senior biotech analyst Brian Orelli gives investors the must-know information, including an in-depth look at the obesity market and reasons to buy and sell both stocks. Click now for an exclusive look at Arena and VIVUS — complete with a full year of free updates — today.

The relevant video segment can be found between 1:25 and 3:01.

Max Macaluso: What are some of the causes of obesity, besides poor diet?

Dr. Domenica Rubino: There’s obviously poor diet, manifested in a lot of different ways in terms of how we eat, and there’s different places that don’t have healthy food, or people who don’t have access to healthy food.

Sedentary — we’re all very, very sedentary. Unfortunately, we mostly drive to work, take the elevator, and sit at our computer, and go home and sit at our computer to relax. Exercise and just generalized movement and activity is a problem and contributes a lot to weight and the development of these diseases.

There are other things, though. Poor sleep. A lot of us — because now we can be up all night, 24/7, on the computer — we don’t get enough rest, and the risk increases for less than five hours of sleep. People have increased risk for weight gain and development of diabetes, and if they have sleep apnea, that’s an issue too.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.